Cargando…
Overall Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Polish Experience
BACKGROUND: The mortality caused by hepatocellular carcinoma is expected to rise in the upcoming decade. Sorafenib has become the preferred systemic treatment option in patients with unresectable HCC. This study aimed to present the median overall survival (OS) in a group of patients with advanced H...
Autores principales: | Straś, Wojciech, Gotlib, Joanna, Małkowski, Piotr, Wasiak, Dariusz, Śliwczyński, Andrzej, Panczyk, Mariusz, Tronina, Olga, Brzozowska, Melania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418957/ https://www.ncbi.nlm.nih.gov/pubmed/34462415 http://dx.doi.org/10.12659/MSM.931856 |
Ejemplares similares
-
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
por: Straś, Wojciech Andrzej, et al.
Publicado: (2022) -
A Ten-Year Longitudinal Study of Prevalence of Eating Disorders in the General Polish Type 2 Diabetes Population
por: Jaworski, Mariusz, et al.
Publicado: (2018) -
Translation and validation study of the Polish version of the Brief Hepatitis C Knowledge Scale
por: Tronina, Olga, et al.
Publicado: (2020) -
Severe Depressive Episode with Psychotic Symptoms and Type 2 Diabetes: A 2010–2017 Longitudinal Study
por: Jaworski, Mariusz, et al.
Publicado: (2019) -
Eating Disorders in Males: An 8-Year Population-Based Observational
Study
por: Jaworski, Mariusz, et al.
Publicado: (2019)